JP2021533166A5 - - Google Patents
Info
- Publication number
- JP2021533166A5 JP2021533166A5 JP2021506492A JP2021506492A JP2021533166A5 JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5 JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021506492 A JP2021506492 A JP 2021506492A JP 2021533166 A5 JP2021533166 A5 JP 2021533166A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- target ligand
- car
- payload drug
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862715666P | 2018-08-07 | 2018-08-07 | |
| US62/715,666 | 2018-08-07 | ||
| PCT/US2019/042726 WO2020033129A1 (en) | 2018-08-07 | 2019-07-21 | Rejuvenation of car t cell |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533166A JP2021533166A (ja) | 2021-12-02 |
| JP2021533166A5 true JP2021533166A5 (enExample) | 2022-07-28 |
| JP7623935B2 JP7623935B2 (ja) | 2025-01-29 |
Family
ID=69415080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506492A Active JP7623935B2 (ja) | 2018-08-07 | 2019-07-21 | Ｃａｒ ｔ細胞の若返り |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210308267A1 (enExample) |
| EP (1) | EP3833400A4 (enExample) |
| JP (1) | JP7623935B2 (enExample) |
| KR (1) | KR20210042125A (enExample) |
| CN (2) | CN116763943A (enExample) |
| AU (1) | AU2019317278B2 (enExample) |
| CA (1) | CA3108710A1 (enExample) |
| SG (1) | SG11202100616VA (enExample) |
| WO (1) | WO2020033129A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| US12144850B2 (en) | 2016-04-08 | 2024-11-19 | Purdue Research Foundation | Methods and compositions for car T cell therapy |
| ES3010559T3 (en) | 2017-02-28 | 2025-04-03 | Endocyte Inc | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| CA3091674A1 (en) | 2018-02-23 | 2019-08-29 | Endocyte, Inc. | Sequencing method for car t cell therapy |
| CN112262214A (zh) | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| SG11202100616VA (en) | 2018-08-07 | 2021-03-30 | Purdue Research Foundation | Rejuvenation of car t cell |
| KR20220163940A (ko) | 2020-02-04 | 2022-12-12 | 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 | 항-디니트로페놀 키메라 항원 수용체 |
| CN115551555A (zh) * | 2020-03-06 | 2022-12-30 | 普渡研究基金会 | 用于修饰car-t细胞活性的方法、化合物和组合物 |
| CN116096861A (zh) * | 2020-04-03 | 2023-05-09 | 赛立维公司 | 过继性细胞转移的增强 |
| WO2022115711A1 (en) * | 2020-11-30 | 2022-06-02 | Purdue Research Foundation | Combinations of small molecule drug conjugate and car-expressing cytotoxic lymphocytes and methods of treating cancer using the same |
| WO2023034341A1 (en) * | 2021-08-30 | 2023-03-09 | Purdue Research Foundation | Conjugates, compositions, and methods for rejuvenation of car t-cells |
| CN118696234A (zh) * | 2022-02-18 | 2024-09-24 | 豪夫迈·罗氏有限公司 | 用于检测样品中的目标分析物的方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| EP1472337A4 (en) | 2001-03-09 | 2008-02-27 | Univ Texas | INDUCTION OF TUMORIMMUNITY BY VARIATIONS OF THE FOLAT BINDING PROTEIN |
| WO2005103250A1 (ja) | 2004-04-26 | 2005-11-03 | Takami Matsuyama | 葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬 |
| MX2010001684A (es) * | 2007-08-15 | 2010-04-21 | Amunix Inc | Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos. |
| AU2010234459A1 (en) | 2009-04-08 | 2011-11-03 | The Regents Of The University Of California | Human protein scaffold with controlled serum pharmacokinetics |
| EP2515651A4 (en) | 2009-12-23 | 2016-01-13 | Endocyte Inc | VITAMIN RECEPTOR-ACTIVE EXTRACTION CONJUGATES FOR THE TREATMENT OF INFLAMMATION |
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| AU2014337385B2 (en) * | 2013-10-15 | 2020-04-30 | The Scripps Research Institute | Chimeric antigen receptor T cell switches and uses thereof |
| CN105829349B (zh) * | 2013-10-15 | 2023-02-03 | 斯克利普斯研究所 | 肽嵌合抗原受体t细胞开关和其用途 |
| CA2931684C (en) * | 2013-12-19 | 2024-02-20 | Novartis Ag | Human mesothelin chimeric antigen receptors and uses thereof |
| WO2015092024A2 (en) * | 2013-12-20 | 2015-06-25 | Cellectis | Method of engineering multi-input signal sensitive t cell for immunotherapy |
| EP3593812A3 (en) * | 2014-03-15 | 2020-05-27 | Novartis AG | Treatment of cancer using chimeric antigen receptor |
| US20170158749A1 (en) | 2014-04-23 | 2017-06-08 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) and methods for making and using the same |
| US20190054117A1 (en) | 2014-12-19 | 2019-02-21 | Novartis Ag | Dimerization switches and uses thereof |
| WO2016164745A1 (en) | 2015-04-10 | 2016-10-13 | The Methodist Hospital System | Cd117 ligand-drug conjugates for targeted cancer therapy |
| WO2017035117A1 (en) * | 2015-08-24 | 2017-03-02 | University Of Houston System | Combination therpay combining car + t cells with appropriately timed immunodulatory antibodies |
| CA3020330A1 (en) * | 2016-04-07 | 2017-10-12 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
| US12144850B2 (en) * | 2016-04-08 | 2024-11-19 | Purdue Research Foundation | Methods and compositions for car T cell therapy |
| CN109475558A (zh) * | 2016-05-25 | 2019-03-15 | 普渡研究基金会 | 通过靶向骨髓衍生的抑制细胞而治疗癌症的方法 |
| US20200237936A1 (en) * | 2016-12-14 | 2020-07-30 | Purdue Research Foundation | Fibroblast activation protein (fap)-targeted imaging and therapy |
| CN118634339B (zh) | 2017-02-17 | 2025-07-01 | 珀杜研究基金会 | 用于细胞疗法的基于靶向性配体-有效负载的药物递送 |
| ES3010559T3 (en) | 2017-02-28 | 2025-04-03 | Endocyte Inc | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| CA3091674A1 (en) | 2018-02-23 | 2019-08-29 | Endocyte, Inc. | Sequencing method for car t cell therapy |
| SG11202100616VA (en) | 2018-08-07 | 2021-03-30 | Purdue Research Foundation | Rejuvenation of car t cell |
| CN115551555A (zh) | 2020-03-06 | 2022-12-30 | 普渡研究基金会 | 用于修饰car-t细胞活性的方法、化合物和组合物 |
| CN120390641A (zh) | 2022-10-19 | 2025-07-29 | 西雅图儿童医院（Dba西雅图儿童研究所） | 采用靶向小分子和抗靶向car t细胞的治疗方法 |
-
2019
- 2019-07-21 SG SG11202100616VA patent/SG11202100616VA/en unknown
- 2019-07-21 KR KR1020217006445A patent/KR20210042125A/ko not_active Ceased
- 2019-07-21 CN CN202310525133.XA patent/CN116763943A/zh active Pending
- 2019-07-21 CN CN201980052586.7A patent/CN112543651B/zh active Active
- 2019-07-21 EP EP19847190.6A patent/EP3833400A4/en active Pending
- 2019-07-21 CA CA3108710A patent/CA3108710A1/en active Pending
- 2019-07-21 AU AU2019317278A patent/AU2019317278B2/en active Active
- 2019-07-21 US US17/266,509 patent/US20210308267A1/en not_active Abandoned
- 2019-07-21 WO PCT/US2019/042726 patent/WO2020033129A1/en not_active Ceased
- 2019-07-21 JP JP2021506492A patent/JP7623935B2/ja active Active
-
2023
- 2023-12-21 US US18/392,939 patent/US12622973B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11913952B2 (en) | Methods for detecting peptide/MHC/TCR binding | |
| Becker et al. | Biogenesis of mitochondria: dual role of Tom7 in modulating assembly of the preprotein translocase of the outer membrane | |
| Rubino et al. | Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes | |
| Ray et al. | Mechanism of active renal tubular efflux of tenofovir | |
| Malheiro et al. | Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation | |
| Gong et al. | α-Amanitin blocks translocation by human RNA polymerase II | |
| Celedon et al. | Stoichiometry for binding and transport by the twin arginine translocation system | |
| Black et al. | NXT1 is necessary for the terminal step of Crm1-mediated nuclear export | |
| Tebar et al. | Calmodulin regulates intracellular trafficking of epidermal growth factor receptor and the MAPK signaling pathway | |
| WO2005116072A3 (en) | Antibodies as t cell receptor mimics, methods of production and uses thereof | |
| WO2008054517A3 (en) | Immunosuppressant binding antibodies and methods of obtaining and using same | |
| JP2017514481A5 (enExample) | ||
| Glander et al. | Inosine 5′-monophosphate dehydrogenase activity as a biomarker in the field of transplantation | |
| Schnell | Shedding light on the chloroplast protein import machinery | |
| Aukrust et al. | Post‐translational modifications of Annexin A2 are linked to its association with perinuclear nonpolysomal mRNP complexes | |
| Mardones et al. | Cis-Golgi matrix proteins move directly to endoplasmic reticulum exit sites by association with tubules | |
| JP2019531716A5 (enExample) | ||
| Adam et al. | Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis | |
| Giri et al. | CXCL12‐induced partitioning of flotillin‐1 with lipid rafts plays a role in CXCR4 function | |
| Sriskanthadevan et al. | C a2+‐calmodulin interacts with D d CAD‐1 and promotes D d CAD‐1 transport by contractile vacuoles in D ictyostelium cells | |
| JP2023552748A (ja) | 細胞表面タンパク質を提示する生物学的小胞及びそれに関連する方法 | |
| Conor Moran et al. | Mitoribosome biogenesis | |
| JP2007528502A5 (ja) | エベロリムスの測定方法および測定キット | |
| WO2003062444A3 (en) | Array systems and methods | |
| JP2004501379A (ja) | マトリクススクリーニング方法 |